Low-density Lipoprotein Receptor-related Protein-1 Facilitates Heme Scavenging After Intracerebral Hemorrhage in Mice
Overview
Endocrinology
Neurology
Authors
Affiliations
Heme-degradation after erythrocyte lysis plays an important role in the pathophysiology of intracerebral hemorrhage. Low-density lipoprotein receptor-related protein-1 is a receptor expressed predominately at the neurovascular interface, which facilitates the clearance of the hemopexin and heme complex. In the present study, we investigated the role of low-density lipoprotein receptor-related protein-1 in heme removal and neuroprotection in a mouse model of intracerebral hemorrhage. Endogenous low-density lipoprotein receptor-related protein-1 and hemopexin were increased in ipsilateral brain after intracerebral hemorrhage, accompanied by increased hemoglobin levels, brain water content, blood-brain barrier permeability and neurological deficits. Exogenous human recombinant low-density lipoprotein receptor-related protein-1 protein reduced hematoma volume, brain water content surrounding hematoma, blood-brain barrier permeability and improved neurological function three days after intracerebral hemorrhage. The expression of malondialdehyde, fluoro-Jade C positive cells and cleaved caspase 3 was increased three days after intracerebral hemorrhage in the ipsilateral brain tissues and decreased with recombinant low-density lipoprotein receptor-related protein-1. Intracerebral hemorrhage decreased and recombinant low-density lipoprotein receptor-related protein-1 increased the levels of superoxide dismutase 1. Low-density lipoprotein receptor-related protein-1 siRNA reduced the effect of human recombinant low-density lipoprotein receptor-related protein-1 on all outcomes measured. Collectively, our findings suggest that low-density lipoprotein receptor-related protein-1 contributed to heme clearance and blood-brain barrier protection after intracerebral hemorrhage. The use of low-density lipoprotein receptor-related protein-1 as supplement provides a novel approach to ameliorating intracerebral hemorrhage brain injury via its pleiotropic neuroprotective effects.
Chen W, Liang C, Peng S, Bao S, Xue F, Lian X Glia. 2024; 73(2):368-380.
PMID: 39530196 PMC: 11662979. DOI: 10.1002/glia.24639.
Wang Y, Li K, Wang J, Hua W, Liu Q, Sun Y World J Diabetes. 2024; 15(9):1979-2001.
PMID: 39280179 PMC: 11372641. DOI: 10.4239/wjd.v15.i9.1979.
Endogenous Ligands of TLR4 in Microglia: Potential Targets for Related Neurological Diseases.
Chen B, Di B Curr Drug Targets. 2024; 25(14):953-970.
PMID: 39234911 DOI: 10.2174/0113894501316051240821060249.
Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage.
Huang R, Pang Q, Zheng L, Lin J, Li H, Wan L Neural Regen Res. 2024; 20(4):1015-1030.
PMID: 38989934 PMC: 11438341. DOI: 10.4103/NRR.NRR-D-23-01462.
Iron homeostasis and post-hemorrhagic hydrocephalus: a review.
Pan S, Hale A, Lemieux M, Raval D, Garton T, Sadler B Front Neurol. 2024; 14:1287559.
PMID: 38283681 PMC: 10811254. DOI: 10.3389/fneur.2023.1287559.